Elise F Nassif Haddad (Elise F Nassif)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 25

Top Venues

Cancers

Current oncology (Toronto, Ont.)

Nature cancer

Current treatment options in oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Prapassorn Thirasastr, Thomas Lee Sutton, Cissimol P Joseph, Heather Lin, Behrang Amini, Skye C Mayo, Dejka Araujo, Robert S Benjamin, Anthony P Conley, Jonathan A Livingston, Joseph Ludwig, Shreyaskumar Patel, Ravin Ratan, Vinod Ravi, Maria A Zarzour, Elise F Nassif Haddad, Michael S Nakazawa, Xiao Zhou, Michael C Heinrich, Neeta Somaiah
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter? Cancers 16 (5) (2024)
Christina Lynn Roland, Elise F Nassif Haddad, Emily Z Keung, Wei-Lien Wang, Alexander J F Lazar, Heather Lin, Manoj Chelvanambi, Edwin Roger Parra Cuentes, Khalida Wani, B Ashleigh Guadagnolo, Andrew J Bishop, Elizabeth M Burton, Kelly K Hunt, Keila E Torres, Barry W Feig, Christopher P Scally, Valerae O Lewis, Justin E Bird, Ravin Ratan, Dejka Araujo, M Alexandra Zarzour, Shreyaskumar Patel, Robert Benjamin, Anthony P Conley, Jonathan A Livingston, Vinod Ravi, Hussein A Tawbi, Patrick P Lin, Bryan S Moon, Robert L Satcher, Bilal Mujtaba, Russell G Witt, Raymond S Traweek, Brandon Cope, Rossana Lazcano, Chia-Chin Wu, Xiao Zhou, Mohammad M Mohammad, Randy A Chu, Jianhua Zhang, Ashish Damania, Pranoti Sahasrabhojane, Taylor Tate, Kate Callahan, Sa Nguyen, Davis Ingram, Rohini Morey, Shadarra Crosby, Grace Mathew, Sheila Duncan, Cibelle F Lima, Jean Yves Blay, Wolf Herman Fridman, Kenna Shaw, Ignacio Wistuba, P Andrew Futreal, Nadim Ajami, Jennifer A Wargo, Neeta Somaiah
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nature cancer 5 (4) (2024)
Lewis Fady Nasr, Marianne Zoghbi, Rossana Lazcano, Michael Nakazawa, Andrew J Bishop, Ahsan S Farooqi, Devarati Mitra, Beverly Ashleigh Guadagnolo, Robert Benjamin, Shreyaskumar Patel, Vinod Ravi, Dejka M Araujo, Andrew Livingston, Maria Alejandra Zarzour, Anthony P Conley, Ravin Ratan, Neeta Somaiah, Alexander J Lazar, Christina Lynn Roland, Emily Z Keung, Elise F Nassif Haddad
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience. Cancers 16 (9) (2024)
Ryan A Denu, Amanda M Dann, Emily Z Keung, Michael S Nakazawa, Elise F Nassif Haddad
The Future of Targeted Therapy for Leiomyosarcoma. Cancers 16 (5) (2024)
Prapassorn Thirasastr, Thomas Lee Sutton, Cissimol P Joseph, Heather Lin, Behrang Amini, Skye C Mayo, Dejka Araujo, Robert S Benjamin, Anthony P Conley, Jonathan A Livingston, Joseph Ludwig, Shreyaskumar Patel, Ravin Ratan, Vinod Ravi, Maria A Zarzour, Elise F Nassif Haddad, Michael S Nakazawa, Xiao Zhou, Michael C Heinrich, Neeta Somaiah
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter? Cancers 16 (5) (2024)
Ryan A Denu, Cissimol P Joseph, Elizabeth S Urquiola, Precious S Byrd, Richard K Yang, Ravin Ratan, Maria Alejandra Zarzour, Anthony P Conley, Dejka M Araujo, Vinod Ravi, Elise F Nassif Haddad, Michael S Nakazawa, Shreyaskumar Patel, Wei-Lien Wang, Alexander J Lazar, Neeta Somaiah
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors. Cancers 16 (9) (2024)
Prapassorn Thirasastr, Thomas Lee Sutton, Cissimol P Joseph, Heather Lin, Behrang Amini, Skye C Mayo, Dejka Araujo, Robert S Benjamin, Anthony P Conley, Jonathan A Livingston, Joseph Ludwig, Shreyaskumar Patel, Ravin Ratan, Vinod Ravi, Maria A Zarzour, Elise F Nassif Haddad, Michael S Nakazawa, Xiao Zhou, Michael C Heinrich, Neeta Somaiah
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter? Cancers 16 (5) (2024)
Ryan A Denu, Amanda M Dann, Emily Z Keung, Michael S Nakazawa, Elise F Nassif Haddad
The Future of Targeted Therapy for Leiomyosarcoma. Cancers 16 (5) (2024)
Lewis Fady Nasr, Marianne Zoghbi, Rossana Lazcano, Michael Nakazawa, Andrew J Bishop, Ahsan S Farooqi, Devarati Mitra, Beverly Ashleigh Guadagnolo, Robert Benjamin, Shreyaskumar Patel, Vinod Ravi, Dejka M Araujo, Andrew Livingston, Maria Alejandra Zarzour, Anthony P Conley, Ravin Ratan, Neeta Somaiah, Alexander J Lazar, Christina Lynn Roland, Emily Z Keung, Elise F Nassif Haddad
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience. Cancers 16 (9) (2024)
Ryan A Denu, Amanda M Dann, Emily Z Keung, Michael S Nakazawa, Elise F Nassif Haddad
The Future of Targeted Therapy for Leiomyosarcoma. Cancers 16 (5) (2024)
Christina Lynn Roland, Elise F Nassif Haddad, Emily Z Keung, Wei-Lien Wang, Alexander J F Lazar, Heather Lin, Manoj Chelvanambi, Edwin Roger Parra Cuentes, Khalida Wani, B Ashleigh Guadagnolo, Andrew J Bishop, Elizabeth M Burton, Kelly K Hunt, Keila E Torres, Barry W Feig, Christopher P Scally, Valerae O Lewis, Justin E Bird, Ravin Ratan, Dejka Araujo, M Alexandra Zarzour, Shreyaskumar Patel, Robert Benjamin, Anthony P Conley, Jonathan A Livingston, Vinod Ravi, Hussein A Tawbi, Patrick P Lin, Bryan S Moon, Robert L Satcher, Bilal Mujtaba, Russell G Witt, Raymond S Traweek, Brandon Cope, Rossana Lazcano, Chia-Chin Wu, Xiao Zhou, Mohammad M Mohammad, Randy A Chu, Jianhua Zhang, Ashish Damania, Pranoti Sahasrabhojane, Taylor Tate, Kate Callahan, Sa Nguyen, Davis Ingram, Rohini Morey, Shadarra Crosby, Grace Mathew, Sheila Duncan, Cibelle F Lima, Jean Yves Blay, Wolf Herman Fridman, Kenna Shaw, Ignacio Wistuba, P Andrew Futreal, Nadim Ajami, Jennifer A Wargo, Neeta Somaiah
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nature cancer 5 (4) (2024)
Christina Lynn Roland, Elise F Nassif Haddad, Emily Z Keung, Wei-Lien Wang, Alexander J F Lazar, Heather Lin, Manoj Chelvanambi, Edwin Roger Parra Cuentes, Khalida Wani, B Ashleigh Guadagnolo, Andrew J Bishop, Elizabeth M Burton, Kelly K Hunt, Keila E Torres, Barry W Feig, Christopher P Scally, Valerae O Lewis, Justin E Bird, Ravin Ratan, Dejka Araujo, M Alexandra Zarzour, Shreyaskumar Patel, Robert Benjamin, Anthony P Conley, Jonathan A Livingston, Vinod Ravi, Hussein A Tawbi, Patrick P Lin, Bryan S Moon, Robert L Satcher, Bilal Mujtaba, Russell G Witt, Raymond S Traweek, Brandon Cope, Rossana Lazcano, Chia-Chin Wu, Xiao Zhou, Mohammad M Mohammad, Randy A Chu, Jianhua Zhang, Ashish Damania, Pranoti Sahasrabhojane, Taylor Tate, Kate Callahan, Sa Nguyen, Davis Ingram, Rohini Morey, Shadarra Crosby, Grace Mathew, Sheila Duncan, Cibelle F Lima, Jean Yves Blay, Wolf Herman Fridman, Kenna Shaw, Ignacio Wistuba, P Andrew Futreal, Nadim Ajami, Jennifer A Wargo, Neeta Somaiah
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nature cancer (2024)
Christina Lynn Roland, Elise F Nassif Haddad, Emily Z Keung, Wei-Lien Wang, Alexander J F Lazar, Heather Lin, Manoj Chelvanambi, Edwin Roger Parra Cuentes, Khalida Wani, B Ashleigh Guadagnolo, Andrew J Bishop, Elizabeth M Burton, Kelly K Hunt, Keila E Torres, Barry W Feig, Christopher P Scally, Valerae O Lewis, Justin E Bird, Ravin Ratan, Dejka Araujo, M Alexandra Zarzour, Shreyaskumar Patel, Robert Benjamin, Anthony P Conley, Jonathan A Livingston, Vinod Ravi, Hussein A Tawbi, Patrick P Lin, Bryan S Moon, Robert L Satcher, Bilal Mujtaba, Russell G Witt, Raymond S Traweek, Brandon Cope, Rossana Lazcano, Chia-Chin Wu, Xiao Zhou, Mohammad M Mohammad, Randy A Chu, Jianhua Zhang, Ashish Damania, Pranoti Sahasrabhojane, Taylor Tate, Kate Callahan, Sa Nguyen, Davis Ingram, Rohini Morey, Shadarra Crosby, Grace Mathew, Sheila Duncan, Cibelle F Lima, Jean Yves Blay, Wolf Herman Fridman, Kenna Shaw, Ignacio Wistuba, P Andrew Futreal, Nadim Ajami, Jennifer A Wargo, Neeta Somaiah
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nature cancer 5 (4) (2024)
Ryan A Denu, Cissimol P Joseph, Elizabeth S Urquiola, Precious S Byrd, Richard K Yang, Ravin Ratan, Maria Alejandra Zarzour, Anthony P Conley, Dejka M Araujo, Vinod Ravi, Elise F Nassif Haddad, Michael S Nakazawa, Shreyaskumar Patel, Wei-Lien Wang, Alexander J Lazar, Neeta Somaiah
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors. Cancers 16 (9) (2024)
Alicia A Gingrich, Elise F Nassif Haddad, Christina Lynn Roland, Emily Z Keung
The Landscape of Immunotherapy for Retroperitoneal Sarcoma. Current oncology (Toronto, Ont.) 30 (2) (2023)
Alicia A Gingrich, Elise F Nassif Haddad, Christina Lynn Roland, Emily Z Keung
The Landscape of Immunotherapy for Retroperitoneal Sarcoma. Current oncology (Toronto, Ont.) 30 (2) (2023)
Alicia A Gingrich, Elise F Nassif Haddad, Christina Lynn Roland, Emily Z Keung
The Landscape of Immunotherapy for Retroperitoneal Sarcoma. Current oncology (Toronto, Ont.) 30 (2) (2023)
Elise F Nassif Haddad, Emily Z Keung, Prapassorn Thirasastr, Neeta Somaiah
Myxoid Liposarcomas: Systemic Treatment Options. Current treatment options in oncology (2023)
Alicia A Gingrich, Elise F Nassif Haddad, Christina Lynn Roland, Emily Z Keung
The Landscape of Immunotherapy for Retroperitoneal Sarcoma. Current oncology (Toronto, Ont.) 30 (2) (2023)
Alicia A Gingrich, Elise F Nassif Haddad, Christina Lynn Roland, Emily Z Keung
The Landscape of Immunotherapy for Retroperitoneal Sarcoma. Current oncology (Toronto, Ont.) 30 (2) (2023)
Alicia A Gingrich, Elise F Nassif Haddad, Christina Lynn Roland, Emily Z Keung
The Landscape of Immunotherapy for Retroperitoneal Sarcoma. Current oncology (Toronto, Ont.) 30 (2) (2023)
Brandon M Cope, Raymond S Traweek, Rossana Lazcano, Emily Z Keung, Alexander J Lazar, Christina Lynn Roland, Elise F Nassif Haddad
Targeting the Molecular and Immunologic Features of Leiomyosarcoma. Cancers 15 (7) (2023)
Prapassorn Thirasastr, Heather Lin, Behrang Amini, Wei-Lien Wang, Jeffrey M Cloutier, Elise F Nassif Haddad, Emily Z Keung, Christina L Roland, Barry W Feig, Dejka Araujo, Robert S Benjamin, Anthony P Conley, John A Livingston, Joseph Ludwig, Shreyaskumar R Patel, Ravin Ratan, Vinod Ravi, Maria Alejandra Zarzour, Xiao Zhou, Neeta Somaiah
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma. Cancer medicine (2022)
Elise F Nassif Haddad, Brandon Cope, Raymond Traweek, Russell G Witt, Derek J Erstad, Christopher P Scally, Prapassorn Thirasastr, Maria Alejandra Zarzour, Joseph Ludwig, Robert Benjamin, Andrew J Bishop, B Ashleigh Guadagnolo, Davis Ingram, Khalida Wani, Wei-Lien Wang, Alexander J Lazar, Keila E Torres, Kelly K Hunt, Barry W Feig, Christina Lynn Roland, Neeta Somaiah, Emily Z Keung
Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center. International journal of cancer 150 (12) (2022)
Elise F Nassif Haddad, Edouard Auclin, Rastilav Bahleda, Charles Honoré, Olivier Mir, Sarah Dumont, Benoite Mery, Khalil Hodroj, Mehdi Brahmi, Olivier Trédan, Isabelle L Ray-Coquard, Jean Yves Blay, Christophe Massard, Axel Le Cesne, Armelle Dufresne
TP53 Mutation as a Prognostic and Predictive Marker in Sarcoma: Pooled Analysis of MOSCATO and ProfiLER Precision Medicine Trials. Cancers 13 (13) (2021)

Elise F Nassif Haddad.css-eqlu8i{font-size:small;padding-left:4px;} (Elise F Nassif)

Publication Activity (10 Years)

Top Topics

Top Venues

Elise F Nassif Haddad (Elise F Nassif)